Font Size: a A A
Keyword [PARP inhibitor]
Result: 1 - 20 | Page: 1 of 3
1. Study Of Protective Effect Of PARP Inhibitor PJ34 On A Mouse Model Of Parkinson's Disease
2. The Design, Synthesis And Neuroprotective Effect Of PARP Inhibitors
3. The Roles Of PARP Inhibitor In Autophagy Induced By Doxorubicin In Multiple Myeloma Cells
4. Effects Of PARP Inhibitor Combined With DDP On Proliferation Of Breast Cancer Line MDA-MB-231 And Cellular Apoptosis
5. Effect Of5-AIQ, PARP Inhibitor, On Severe Acute Pancreatitis Associated Lung Injury And The Mechanisms
6. Effects Of Transfection INPP4B Gene Combined With PARP Inhibitor In Castration Therapy-Resistant Prostate Cancer Cell Line PC3
7. Inpp4B Over-expression Enhances The Anti-tumor Efficacy Of PARP Inhibitor AG014699in MDA-MB-231Triple-negative Breast Cancer Cells
8. WZ-8, A New PARP Inhibitor, Exhibits Potent Antitumor Effects In Vitro And In Vivo
9. Screening And Activity Evaluation Of PARP Inhibitors
10. Primary Research Of The Inhibition Of PARP Inhibitor,Salin Omycin, Everolimus And Sunitinib On Breast Cancer BT-20 Stem Cells
11. Poly ADP-ribose Polymerase(PARP) Inhibitor AG014699 Improve Radiosensitivity Of BRCA2 Deficient Pancreatic Cancer Cells In Vitro Experimental Study
12. X-Ray Irradiation And Veliparib Induce Accelerated Senescence Of Mouse Breast Cancer Cell Line
13. PARP Inhibitor Increases Chemosensitivity By Upregulating MiR-664b-5p In BRCA1-mutated Triple-negative Breast Cancer
14. Meta Analysis Of The Efficacy And Safety Of Poly(ADP-ribose) Polymerase (PARP) Inhibitors In The Treatment Of Ovarian Cancer
15. PARP1 Inhibition Retards Tumor Growth By Inducing Oxidative Stress In Tumor Cells And By Impeding M2 Polarization In Tumor-associated Macrophages
16. The Roles Of The Deubiquitylating Enzyme USP15 In Homologous Recombination Repair And Breast Cancer Cell Responseto Chemotherapy
17. BRCAness In Renal Cell Carcinoma:Therapeutic Implications?—Resistance Of RCC To PARPis And The Underlying Mechanism
18. The Sensitizing Effect Of Mir-509-3 On PARP Inhibitors In High-grade Serous Ovarian Cancer Based On PDX Models
19. Synthetic Lethal Interactions Between PARP Inhibition And Alantolactone-induced Oxidative DNA Damage In Cancer Cells
20. Investigating The Therapeutic Effect Of Olaparib And Palbociclib In Ovarian Cancer And Its Underlying Mechanism
  <<First  <Prev  Next>  Last>>  Jump to